Dasatinib suppresses particulate-induced pyroptosis and acute lung inflammation
Background: Humans are constantly exposed to various industrial, environmental, and endogenous particulates that result in inflammatory diseases. After being engulfed by immune cells, viz. Macrophages, such particulates lead to phagolysosomal dysfunction, eventually inducing pyroptosis, a form of ce...
Main Authors: | Yixi Pan, Kenta Ikoma, Risa Matsui, Akiyoshi Nakayama, Naoki Takemura, Tatsuya Saitoh |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1250383/full |
Similar Items
-
Dasatinib and Trametinib Promote Anti-Tumor Metabolic Activity
by: Eric L. Bolf, et al.
Published: (2023-05-01) -
Dasatinib reverses drug resistance by downregulating MDR1 and Survivin in Burkitt lymphoma cells
by: Mitsuki Tabata, et al.
Published: (2020-03-01) -
A Phase I Trial of Dasatinib and Osimertinib in TKI Naïve Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer
by: Chul Kim, et al.
Published: (2021-09-01) -
Monitoring Src status after dasatinib treatment in HER2+ breast cancer with 89Zr-trastuzumab PET imaging
by: Brooke N. McKnight, et al.
Published: (2018-10-01) -
Treatment of Recurrent Intracranial Hemangiopericytoma with SRC-Related Tyrosine Kinase Targeted Therapy: A Case Report
by: Katherine B. Peters, et al.
Published: (2010-04-01)